knowledge -WSS

knowledge

author：knowledge 2025-10-01 20:14:39 - browse：4

UnitedHealthcare (UHC) health insurance company signage is displayed on an office building in Phoenix, Arizona — PATRICK T. FALLON/AFP via Getty Images

UnitedHealth Group has made it clear that more people, especially older adults, are seeing their doctors and getting more medical care this year. But that is certainly not dragging down the company’s profits.

In the third quarter of this year, UnitedHealth’s net profit increased by more than 11%, to more than $5.8 billion, the company reported Friday.

UnitedHealthcare, the health insurance division of the conglomerate, registered a medical loss ratio of 82.3% in the quarter. That means for every $100 in premiums the company collected, it paid out $82.30 to hospitals, doctors, and other providers — and kept the rest as profit and to cover its own expenses. That ratio was lower than the 82.8% that Wall Street had predicted for the quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Poor hospice wound care hurts patients and families

focus

explore

WSS

Why medical students are struggling with mental health

Why medical students are struggling with mental health

David Sabatini, ex

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

A daunting task: navigating dual Medicare, Medicaid eligibility

hotspot

knowledge

focus

In age of alternative facts, a scholarly course on calling out crap

U.K. considers world's first use of meningitis vaccine to address gonorrhea

DIEP, the 'gold standard' of breast reconstruction, is under threat

Weight loss drug costs may need more research, senator suggests

Dobbs anniversary: the lost opportunity of abortion as health care

Does good food count as health care? Study aims to find out

Novavax promises a turnaround & Lilly roils the obesity market

A daunting task: navigating dual Medicare, Medicaid eligibility

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Wikipedia

Gain of function research would be limited under House proposal

Morphosys mixed study results for blood cancer drug

CRISPR pioneers react to Casgevy, first gene

Astellas still sees hope in its gene therapy after four deaths

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

U.K. considers world's first use of meningitis vaccine to address gonorrhea

focus

explore

explore

hotspot